首页> 外国专利> use of a compound, method for treating one or more of the following indications, congestive heart failure, angina, arrhythmias, circulatory disorders such as raynaud's phenomenon, migraine and anxiety and anxiety disorders, and, pharmaceutical composition

use of a compound, method for treating one or more of the following indications, congestive heart failure, angina, arrhythmias, circulatory disorders such as raynaud's phenomenon, migraine and anxiety and anxiety disorders, and, pharmaceutical composition

机译:化合物的用途,治疗以下一种或多种适应症,充血性心力衰竭,心绞痛,心律不齐,循环系统疾病(如雷诺现象),偏头痛,焦虑症和焦虑症的方法以及药物组合物

摘要

USE OF A COMPOUND, METHOD TO TREAT ONE OR MORE OF THE FOLLOWING INDICATIONS, CONGESTIVE HEART FAILURE, ANGINA, ARRHYTHMIAS, CIRCULATORY DISORDERS SUCH AS RAYNAUD PHENOMENON, MIGRAINE AND ANXIETY AND ANXIETY AND ANXIETY AND ANXIETY. Use of a compound of formula I, where R ~ 1 ~, R ~ 2 ~ and R ~ 3 ~ are the same or different and mean hydrogens, halogens, alkyl, alkylaryl, alkyloxy, hydroxy, nitro, amino, alkylcarbonylamino, alkylamino group or dialkylamino; R ~ 4 ~ means hydrogen, alkyl or alkylaryl group; X means CH ~ 2 ~, oxygen atom or sulfur atom; n is 1, 2 or 3, with the proviso that when n is 1, X will not be CH ~ 2 ~ and the individual (R) and (S) enantiomers or mixtures of enantiomers and their pharmaceutically acceptable salts; wherein the term alkyl means hydrocarbon chains, straight or branched, containing from one to six carbon atoms, optionally substituted by aryl, alkoxy, halogen, alkoxycarbonyl or hydroxycarbonyl groups; the term aryl means a phenyl or naflula group, optionally substituted by an alkyloxy, halogen or nitro group; the term halogen means fluorine, chlorine, bromine or iodine, in the manufacture of a medicine for the treatment for one or more of the following indications, congestive heart failure, angina, arrhythmias, circulatory disorders, such as Raynaud's phenomenon, migraine and anxiety disorders .
机译:使用一种或多种方法治疗以下适应症,心律失常,心绞痛,心律失常,循环系统疾病(如雷诺德现象),偏头痛和焦虑症以及焦虑,焦虑和焦虑症中的一种或多种。使用式I的化合物,其中R 1〜,R 2〜和R 3〜相同或不同,并且是指氢,卤素,烷基,烷基芳基,烷氧基,羟基,硝基,氨基,烷基羰基氨基,烷基氨基或二烷基氨基; R〜4〜表示氢,烷基或烷基芳基; X表示CH 2〜,氧原子或硫原子; n为1、2或3,条件是当n为1时,X不为CH 2〜,并且单独的(R)和(S)对映异构体或对映异构体及其药学上可接受的盐的混合物;其中烷基是指直链或支链的含1-6个碳原子的烃链,可被芳基,烷氧基,卤素,烷氧羰基或羟羰基取代;术语芳基是指任选地被烷氧基,卤素或硝基取代的苯基或萘氟拉基;术语卤素是指在制造用于治疗以下一种或多种适应症,充血性心力衰竭,心绞痛,心律不齐,循环系统疾病(如雷诺现象),偏头痛和焦虑症的药物时,氟,氯,溴或碘。

著录项

  • 公开/公告号BRPI0806514A2

    专利类型

  • 公开/公告日2011-09-13

    原文格式PDF

  • 申请/专利权人 BIAL - PORTELA & C.A. S.A.;

    申请/专利号BR2008PI06514

  • 申请日2008-01-10

  • 分类号A61P9/04;A61K31/4164;A61K31/4178;A61K45/06;A61P9/06;A61P9/10;A61P25/06;A61P25/22;

  • 国家 BR

  • 入库时间 2022-08-21 18:07:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号